EXMceuticals aiming to be 'largest volume and lowest cost' producer of CBD products

Jonathan Summers, chairman of EXMceuticals Inc (CSE:EXM), introduces the business to Proactive London's Andrew Scott.

''The plan for the business, which we've already embarked on and are executing, is to grow large volumes of cannabis in Africa on an industrial scale, process that locally, refine it in Portugal and access all the end markets in North America and Europe.

''If you just look at Europe and ignore the rest of the world you have 750 million people who are increasingly interested and getting very excited about CBD as a health supplement and I think the potential for this industry and companies in this space, if they execute, could be very substantial''.

Quick facts: EXMceuticals

Price: $1.35

Market: CSE
Market Cap: $50.43 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EXMceuticals named herein, including the promotion by the Company of EXMceuticals in any Content on the Site, the Company receives from said...



EXMceuticals is one of the few cannabis companies working in Africa

EXMceuticals Inc (CSE:EXM) (FSE:EXM) COO Tanek Amin sat down with Proactive Investors at the MjMicro Cap Conference in New York.  The Vancouver, Canada based cannabis company is in the final stage of procuring the required authorizations and permits in Portugal for its laboratory for...

on 25/6/19

2 min read